The aberrant activation of GSK-3β in AD leads to Tau protein hyperphosphorylation, preventing its binding to microtubules and resulting in neurodegeneration, ultimately contributing to the pathological outcomes of AD [25]. Here, GSK3B is linked to Alzheimer disease.